T 1133/21 (Adaptative infant formula/NESTLÉ) of 26.05.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T113321.20230526
- Date of decision
- 26 May 2023
- Case number
- T 1133/21
- Petition for review of
- -
- Application number
- 15771909.7
- IPC class
- A23L 33/10A23L 33/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 123(2)
- Application title
- INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOS)
- Applicant name
- Société des Produits Nestlé S.A.
- Opponent name
- Reckitt Benckiser Health Limited
N.V. Nutricia - Board
- 3.3.09
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)
- Keywords
- Main request and auxiliary requests 1 to 4: selection from lists of converging alternatives - added matter - (yes)
- Catchword
- The mere fact that features are described in the application as filed in terms of lists of more or less converging alternatives does not give the proprietor a "carte blanche" for freely combining features selected from a first list with features selected from a second list disclosed in the application as filed. Any such amendment will only be allowable under Article 123(2) EPC if it complies with the "gold standard" defined in decision G 2/10 (reasons 2.15 of the present decision).
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.